Trial Profile
A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Genital warts
- Focus Registrational; Therapeutic Use
- Sponsors Graceway Pharmaceuticals
- 19 Jul 2011 Company added in the association field, additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 10 Jul 2010 Results from a pooled analysis of phase III trials evaluating the use of imiquimod for the treatment of genital warts have been presented at the Human Papillomavirus Conference, Montreal, 3-8 Jul 2010, according to a Graceway media release.
- 29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.